Figure 2From: Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [18F]fluciclatide kinetics and [15O]H2O PET Time-activity curves for (A) [ 15 O]H 2 O and (B) [ 18 F]fluciclatide. Back to article page